ENANTA PHARMACEUTICALS, INC Write off of Deferred Debt Issuance Cost
ENANTA PHARMACEUTICALS, INC (ENTA) reported Write off of Deferred Debt Issuance Cost of $150.00 thousand for the 1-month period ending 2010-12-31, per its 10-K filed 2013-12-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2013-12-18
- 2010-12-31: Write off of Deferred Debt Issuance Cost 1 month $150.00K.
| Period end | Write off of Deferred Debt Issuance Cost 1 month |
|---|---|
| 2010-12-31 | $150.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |